Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Andreas Carus"'
Autor:
Gry Assam Taarnhøj, Christoffer Johansen, Andreas Carus, Rikke Hedegaard Dahlrot, Line Hammer Dohn, Niels Henrik Hjøllund, Mark Bech Knudsen, Anders Tolver, Henriette Lindberg, Helle Pappot
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Background Patient-reported outcomes (PROs) are getting widely implemented, but little is known of the impact of applying PROs in specific cancer diagnoses. We report the results of a randomized controlled trial (RCT) of the active use of PR
Externí odkaz:
https://doaj.org/article/a3952550718d4f76bcd8865f320b0fad
Autor:
Lise H. Omland, Henriette Lindberg, Andreas Carus, Anne Birgitte Als, Niels Viggo Jensen, Gry A. Taarnhøj, Redas Trepiakas, Charlotte Suetta, Lars H. Omland, Helle Pappot
Publikováno v:
European Urology Open Science, Vol 24, Iss , Pp 1-8 (2021)
Background: Real-world treatment patterns and survival outcomes of locally advanced, unresectable, and metastatic urinary tract cancer (mUTC) patients have not previously been studied in a nationwide, population-based cohort. Objective: To describe t
Externí odkaz:
https://doaj.org/article/6aec2ef0cde54a55b3248ced74cbf8a7
Publikováno v:
Landgrebe, M, Tobberup, R, Carus, A & Rasmussen, H H 2023, ' GLIM diagnosed malnutrition predicts clinical outcomes and Quality of Life in patients with non-small cell lung cancer ', Clinical Nutrition, vol. 42, no. 2, pp. 190-198 . https://doi.org/10.1016/j.clnu.2022.12.011
Background & aims: The high prevalence of malnutrition in non-small cell lung cancer (NSCLC) patients has numerous negative consequences on patients’ outcome when undergoing anti-neoplastic treatment. The Global Leadership Initiative on Malnutritio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa566e83d717e9cb9bc2b07ba2b4d5b
https://vbn.aau.dk/da/publications/43d533e8-9dd0-4a31-a566-d8d02998978d
https://vbn.aau.dk/da/publications/43d533e8-9dd0-4a31-a566-d8d02998978d
Autor:
Lærke Kjær Tolstrup, Anne Birgitte Als, Andreas Carus, Rikke Dahlrot, Line Hammer Dohn, Cecilie Holländer-Mieritz, Gry Taarnhøj, Helle Pappot
Publikováno v:
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol–a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47808e785bc622e7b1bb6fc968cd8b6
https://pure.au.dk/portal/da/publications/the-iblad-app-protocola-national-exploratory-study-on-a-multimodality-smartphone-app-in-bladder-cancer-for-better-understanding-symptoms-quality-of-life-and-need-for-supportive-care(e00dc9bb-f897-4662-8bf4-84d250af2f1e).html
https://pure.au.dk/portal/da/publications/the-iblad-app-protocola-national-exploratory-study-on-a-multimodality-smartphone-app-in-bladder-cancer-for-better-understanding-symptoms-quality-of-life-and-need-for-supportive-care(e00dc9bb-f897-4662-8bf4-84d250af2f1e).html
Autor:
Morten Ladekarl, Anne Krogh Nøhr, Mads Sønderkær, Simon Christian Dahl, Lone Sunde, Charles Vestereghem, Christophe Kamungu Mapendano, Charlotte Aaquist Haslund, Anja Pagh, Andreas Carus, Tamás Lörincz, Kinga Nowicka-Matus, Laurids Ø. Poulsen, René Johannes Laursen, Karen Dybkær, Birgitte Klindt Poulsen, Jens Brøndum Frøkjær, Anja Høegh Brügmann, Anja Ernst, Alkwin Wanders, Martin Bøgsted, Inge Søkilde Pedersen
Publikováno v:
Ladekarl, M, Nøhr, A K, Sønderkær, M, Dahl, S C, Sunde, L, Vestereghem, C, Mapendano, C K, Haslund, C A, Pagh, A, Carus, A, Lörincz, T, Nowicka-Matus, K, Poulsen, L Ø, Laursen, R J, Dybkær, K, Poulsen, B K, Frøkjær, J B, Brügmann, A H, Ernst, A, Wanders, A, Bøgsted, M & Pedersen, I S 2023, ' Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital ', Acta Oncologica, vol. 62, no. 3, pp. 261-271 . https://doi.org/10.1080/0284186X.2023.2185542
Aim: Our goal was to describe a precision medicine program in a regional academic hospital, characterize features of included patients and present early data on clinical impact. Materials and methods: We prospectively included 163 eligible patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f38853d83a71ac56e8c41e5f081f5dd
Publikováno v:
Carus, A, Holmsten, K, Pappot, H & Ullén, A 2022, ' The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer : still an open question? ', Acta Oncologica, vol. 61, no. 12, pp. 1515-1516 . https://doi.org/10.1080/0284186X.2022.2153620
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46fb38ec146cfa64e010cb27423c8995
https://pubmed.ncbi.nlm.nih.gov/36484326
https://pubmed.ncbi.nlm.nih.gov/36484326
Autor:
Stine Nyby, Signe Hertz Hansen, Sophie Yammeni, Agnieszka Monika Delekta, Gintare Naujokaite, Ursula G. Falkmer, Martin Bøgsted, Andreas Carus
Purpose: Breast cancer patients scheduled for postoperative radiotherapy undergo radiotherapy-planning computed tomography (CT), and incidental findings (IFs) may appear. This study investigated the interobserver variability between radiologists and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b26aa49a254b94214a71e01ea1c83ac2
https://doi.org/10.21203/rs.3.rs-1214703/v1
https://doi.org/10.21203/rs.3.rs-1214703/v1
Autor:
Mette T. Mouritzen, Karen F. Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W. M. Nielsen, Anna Livbjerg, Jacob W. Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H. Hansen, Anne-Cathrine Østby, Malene S. Frank, Jakob Lauritsen, Jens B. Sørensen, Seppo W. Langer, Gitte F. Persson, Jon L. Andersen, Pernille H. Homann, Emilie B. Kristensen, Lars B. Drivsholm, Martin Bøgsted, Heidi S. Christensen, Mette Pøhl, Birgitte Bjørnhart
Publikováno v:
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta oncologica (Stockholm, Sweden), vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta Oncologica, vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
Mouritzen, M T, Junker, K F, Carus, A, Ladekarl, M, Meldgaard, P, Nielsen, A W M, Livbjerg, A, Larsen, J W, Skuladottir, H, Kristiansen, C, Wedervang, K, Schytte, T, Hansen, K H, Østby, A-C, Frank, M S, Lauritsen, J, Sørensen, J B, Langer, S W, Persson, G F, Andersen, J L, Homann, P H, Kristensen, E B, Drivsholm, L B, Bøgsted, M, Christensen, H S, Pøhl, M & Bjørnhart, B 2022, ' Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC : a Danish nationwide real-world study ', Acta oncologica (Stockholm, Sweden), vol. 61, no. 4, pp. 409-416 . https://doi.org/10.1080/0284186X.2021.2023213
BACKGROUND: Immune checkpoint inhibitors (ICIs) are implemented as standard treatment for patients with advanced non-small cell lung cancer (NSCLC) in first-line and subsequent-line treatment. However, certain subgroups such as patients with older ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a02ba76beaf13455a12c49ea8e04bb
https://vbn.aau.dk/da/publications/686eb154-1718-4f76-8653-85dceaffd10e
https://vbn.aau.dk/da/publications/686eb154-1718-4f76-8653-85dceaffd10e
Autor:
Karin Holmsten, Lise Høj Omland, Anne Birgitte Als, Mads Agerbæk, Line Hammer Dohn, Henriette Lindberg, Niels Viggo Jensen, Andreas Carus, Mette Moe, Abolfazl Hosseini, Cecilia Radkiewicz, Helle Pappot, Anders Ullén
Publikováno v:
Holmsten, K, Omland, L H, Als, A B, Agerbæk, M, Dohn, L H, Lindberg, H, Jensen, N V, Carus, A, Moe, M, Hosseini, A, Radkiewicz, C, Pappot, H & Ullén, A 2022, ' Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer : Three-Week Versus Four-Week Regimen ', Bladder Cancer, vol. 8, no. 1, pp. 71-80 . https://doi.org/10.3233/BLC-211556
BACKGROUND: Neoadjuvant cisplatin-based chemotherapy is standard care prior to radical cystectomy in patients with muscle-invasive bladder cancer (MIBC). OBJECTIVE: To assess efficacy and safety of two commonly used neoadjuvant schedules with differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5eda6329980f4b6fa846cf3a7cefde
https://findresearcher.sdu.dk:8443/ws/files/200459053/blc_2022_8_1_blc_8_1_blc211556_blc_8_blc211556.pdf
https://findresearcher.sdu.dk:8443/ws/files/200459053/blc_2022_8_1_blc_8_1_blc211556_blc_8_blc211556.pdf
Autor:
Andreas Carus, L.H. Dohn, Anne Birgitte Als, Gry Assam Taarnhj, Dag Rune Stormoen, Lise Høj Omland, Anders Tolver, Helle Pappot, Niels Viggo Jensen
Publikováno v:
Omland, L H, Stormoen, D R, Dohn, L H, Carus, A, Als, A B, Jensen, N V, Taarnhøj, G A, Tolver, A & Pappot, H 2021, ' Real-World Study of Treatment with Pembrolizumab among Patients with Advanced Urothelial Tract Cancer in Denmark ', Bladder Cancer, vol. 7, no. 4, pp. 413-425 . https://doi.org/10.3233/BLC-211523
BACKGROUND:Investigating the effect of newly approved oncological drugs in the real-world is warranted. With emerging novel treatments rapidly being approved for urothelial tract cancers, we aimed to assess real-world data, regarding effect and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c190fcf7b49a4c54b147da56a859cb93
https://vbn.aau.dk/da/publications/df178afd-c10f-4c62-b08a-f9faf5b961bb
https://vbn.aau.dk/da/publications/df178afd-c10f-4c62-b08a-f9faf5b961bb